ConductScience.org, home

Paper24948971

Association of Hepatitis C Virus Infection and Interleukin-28B Gene Polymorphism in Chinese Children.

Wu RR and 3 others. Pak J Med Sci, 2014. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Association of Hepatitis C Virus Infection and Interleukin-28B Gene Polymorphism in Chinese Children. Papers, record 24948971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24948971

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association of Hepatitis C Virus Infection and Interleukin-28B Gene Polymorphism in Chinese Children.
PubMed
Journal
Pak J Med Sci
PubMed
Year
2014
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.11
iCite
Revised in PubMed
2021-10-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu RRRong-Rong
2Liu FQFeng-Qun
3Zhu SSShi-Shu
4Han JJin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122329371IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.J Viral Hepat2012https://conductscience.org/library/papers/22329371PubMed
218486955Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.Public Health2008https://conductscience.org/library/papers/18486955PubMed
317087946Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.Gastroenterology2006https://conductscience.org/library/papers/17087946PubMed
422649509IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population.PLoS One2012https://conductscience.org/library/papers/22649509PubMed
519344247Acute hepatitis C: prevention and treatment.Expert Rev Anti Infect Ther2009https://conductscience.org/library/papers/19344247PubMed
624144988Evaluation of the relationship between IL28B, IL10RB and IL28RA single-nucleotide polymorphisms and susceptibility to hepatitis C virus in Chinese Han population.Infect Genet Evol2014https://conductscience.org/library/papers/24144988PubMed
719330875Diagnosis, management, and treatment of hepatitis C: an update.Hepatology2009https://conductscience.org/library/papers/19330875PubMed
818834319Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.Clin Infect Dis2008https://conductscience.org/library/papers/18834319PubMed
919759533Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.Nature2009https://conductscience.org/library/papers/19759533PubMed
1017568824Management of chronic hepatitis C: consensus guidelines.Can J Gastroenterol2007https://conductscience.org/library/papers/17568824PubMed
1123918534Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1.J Med Virol2013https://conductscience.org/library/papers/23918534PubMed
1220400194Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents.J Hepatol2010https://conductscience.org/library/papers/20400194PubMed
1316934072The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders.Transfusion2006https://conductscience.org/library/papers/16934072PubMed
1420374226Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy.Aliment Pharmacol Ther2010https://conductscience.org/library/papers/20374226PubMed
1518174875Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection.Pediatr Infect Dis J2008https://conductscience.org/library/papers/18174875PubMed
1616250032Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics.Hepatology2005https://conductscience.org/library/papers/16250032PubMed
1721146242IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.J Hepatol2011https://conductscience.org/library/papers/21146242PubMed
1823782163Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody-positive blood donors in China.Transfusion2013https://conductscience.org/library/papers/23782163PubMed
1921413051Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children.Hepatology2011https://conductscience.org/library/papers/21413051PubMed
2019684573Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.Nature2009https://conductscience.org/library/papers/19684573PubMed

See all 24 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
34216268Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis.Arch Virol2021https://conductscience.org/library/papers/34216268PubMed
26478670What's new in hepatitis C virus infections in children?World J Gastroenterol2015https://conductscience.org/library/papers/26478670PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNL3282617PubTator's text mininghttps://conductscience.org/library/genes/282617NCBI Gene
IFNLR1163702PubTator's text mininghttps://conductscience.org/library/genes/163702NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL10RB3588PubTator's text mininghttps://conductscience.org/library/genes/3588NCBI Gene
PAEP5047PubTator's text mininghttps://conductscience.org/library/genes/5047NCBI Gene
SLC17A526503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24948971

GET https://conductscience.org/api/papers/v1/24948971/references?page=2